SwipeRx has secured $10 million in fresh funds as part of a new Series B2 round. This round marks investments from marquee investors such as global pharma Sanofi’s Global Health Unit and Cercano Management (formerly Microsoft co-founder Paul Allen’s Vulcan Capital). Existing investors Susquehanna International Group (SIG), Johnson & Johnson and Patamar Capital also participated.

The firm had announced the raise of its $27 million Series B round in May 2022. The prior Series B round was led by Indonesia’s MDI Ventures with participation from other global investors, including the Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures, SIG and other existing investors.

With the fresh funds raised, SwipeRx will expand its Business to Business (B2B) commerce platform for the pharmaceutical industry in key markets. The firm will also use the proceeds to invest in specialised healthcare logistics and financing, further grow its pharmacy network in these key markets and strengthen its advanced data teams.

With its corporate headquarters in Singapore and a strong presence in Indonesia, The Philippines, Vietnam, Malaysia, Thailand and Cambodia, the startup is backed by a set of global investors.